Lazard Asset Management LLC bought a new position in Auna S.A. (NYSE:AUNA – Free Report) in the 1st quarter, Holdings Channel.com reports. The fund bought 101,102 shares of the company’s stock, valued at approximately $557,000.
Other institutional investors have also bought and sold shares of the company. Renaissance Technologies LLC raised its holdings in Auna by 487.7% during the first quarter. Renaissance Technologies LLC now owns 668,457 shares of the company’s stock valued at $3,683,000 after acquiring an additional 554,707 shares during the period. Marshall Wace LLP boosted its stake in shares of Auna by 391.0% in the fourth quarter. Marshall Wace LLP now owns 162,992 shares of the company’s stock worth $802,000 after acquiring an additional 129,799 shares during the period. Goldman Sachs Group Inc. boosted its stake in shares of Auna by 43.1% in the fourth quarter. Goldman Sachs Group Inc. now owns 71,645 shares of the company’s stock worth $352,000 after acquiring an additional 21,579 shares during the period. Hsbc Holdings PLC purchased a new stake in shares of Auna during the first quarter worth about $324,000. Finally, Arrowstreet Capital Limited Partnership bought a new stake in Auna during the 1st quarter valued at approximately $316,000.
Insiders Place Their Bets
In other Auna news, President Leon Jesus Zamora purchased 30,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The shares were bought at an average price of $4.39 per share, with a total value of $131,700.00. Following the completion of the purchase, the president directly owned 45,914 shares in the company, valued at $201,562.46. This trade represents a 188.51% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director John Wilton sold 17,574 shares of the stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $4.17, for a total transaction of $73,283.58. Following the transaction, the director owned 49,974 shares of the company’s stock, valued at $208,391.58. This trade represents a 26.02% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders purchased 83,454 shares of company stock valued at $357,063.
Auna Price Performance
Auna (NYSE:AUNA – Get Free Report) last released its quarterly earnings results on Friday, May 15th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.19 by ($0.14). The firm had revenue of $336.84 million for the quarter, compared to analysts’ expectations of $320.54 million. Auna had a net margin of 1.53% and a return on equity of 16.25%. On average, equities research analysts forecast that Auna S.A. will post 0.79 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Several research analysts have weighed in on AUNA shares. Weiss Ratings restated a “sell (d)” rating on shares of Auna in a research note on Wednesday, June 24th. Wall Street Zen cut shares of Auna from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 5th. Finally, JPMorgan Chase & Co. lowered their target price on shares of Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a report on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Auna presently has a consensus rating of “Hold” and a consensus price target of $6.97.
View Our Latest Stock Analysis on AUNA
About Auna
Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.
The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.
Read More
- Five stocks we like better than Auna
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Want to see what other hedge funds are holding AUNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Auna S.A. (NYSE:AUNA – Free Report).
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
